Request for Solidarity from Korea: Gleevec price reduction

Korean civil society has asked KEI to disseminate this request for solidarity and action in their efforts to reduce the price of Gleevec, a leukemia treatment pill. The current price is approximately 2,300 USD per month for an adult patient and the Korean government has been sued by Novartis for trying to reduce the price a 14%. Korean civil society is also requesting Novartis to introduce a higher form, 400 mg, in Korea.

REQUEST for Solidarity:

Korea FTA

Earlier this week, I met in Seoul with civil society fighting the Korus FTA. They are generally opposed to reopening negotiations at this point, but if they do, they hope to have the intellectual property and access to medicines provisions reopened.

Syndicate content